French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on June 17, 2026

Jun. 17, 2026

Bioxtreme Launches Next Generation Dextreme™ System Delivering Up to 2x Greater Stroke Recovery Improvements Than Standard Robotic Therapy

Indeterminate GlobeNewswire

Jun. 17, 2026

Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series

Indeterminate GlobeNewswire

Jun. 17, 2026

Amber Implants Advances Pivotal European EXPAND Study of VCFix® Spinal System in Standalone Vertebral Reconstruction

Indeterminate GlobeNewswire

Jun. 17, 2026

Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

Indeterminate GlobeNewswire

Jun. 17, 2026

BPGbio Presents Latest Clinical and Translational Findings Supporting BPM31510 in Primary CoQ10 Deficiency at Mito Med 2026

Indeterminate GlobeNewswire

Jun. 17, 2026

Precision Neuroscience™ Wins 2026 Webby Award; Earns Back-to-Back Fast Company World Changing Ideas Honor

Indeterminate GlobeNewswire

Jun. 17, 2026

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Indeterminate GlobeNewswire

Jun. 17, 2026

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Indeterminate GlobeNewswire

Jun. 17, 2026

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Indeterminate GlobeNewswire

Jun. 17, 2026

TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets

Indeterminate GlobeNewswire

Jun. 17, 2026

Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform

Indeterminate GlobeNewswire

Jun. 17, 2026

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

Indeterminate GlobeNewswire

Jun. 17, 2026

Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

Indeterminate GlobeNewswire

Jun. 17, 2026

Merakris Therapeutics Awarded U.S. Department of Veterans Affairs Federal Supply Schedule Contract, Expanding Federal Market Access for Dermacyte® AC Matrix Amniotic Membrane Allograft

Indeterminate GlobeNewswire

Jun. 17, 2026

Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 17, 2026

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Indeterminate GlobeNewswire

Jun. 17, 2026

Trevi Therapeutics Announces Upcoming June and July Event Schedule  

Indeterminate GlobeNewswire

Jun. 17, 2026

Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

Indeterminate GlobeNewswire

Jun. 17, 2026

CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment

Indeterminate GlobeNewswire

Jun. 17, 2026

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

Indeterminate GlobeNewswire